All Stories

  1. Neurophysiological Mechanisms Related to Pain Management in Bone Tumors

    Article • Current Neuropharmacology, March 2021, Bentham Science Publishers

    PhD Martin Perez-Santos

  2. Bispecific anti-OX40/CTLA-4 antibodies for advanced solid tumors: a patent evaluation of WO2018202649

    Article • Expert Opinion on Therapeutic Patents, October 2019, Taylor & Francis

    PhD Martin Perez-Santos, Lourdes Millán Pérez Peña

  3. LAG-3 antagonists by cancer treatment: a patent review

    Article • Expert Opinion on Therapeutic Patents, July 2019, Taylor & Francis

    PhD Martin Perez-Santos

  4. Cancer immunotherapy using anti-TIM3/PD-1 bispecific antibody: a patent evaluation of EP3356411A1

    Article • Expert Opinion on Therapeutic Patents, July 2019, Taylor & Francis

    PhD Martin Perez-Santos, Lourdes Millán Pérez Peña

  5. Cancer combinatorial immunotherapy using anti-OX40 agonist and anti-PD-L1 antagonist: a patent evaluation of US2018256711A1

    Article • Expert Opinion on Therapeutic Patents, June 2019, Taylor & Francis

    PhD Martin Perez-Santos, Lourdes Millán Pérez Peña

  6. Treatment of cancer with a combination of LAG-3Ig and anti-PD-1/anti-PD-L1 antibodies: a patent evaluation of US2018271940 A1

    Article • Expert Opinion on Therapeutic Patents, April 2019, Taylor & Francis

    PhD Martin Perez-Santos

  7. Emerging Drugs for the Treatment of Breast Cancer Brain Metastasis: A Review of Patent Literature

    Article • Recent Patents on Anti-Cancer Drug Discovery, April 2018, Bentham Science Publishers

    PhD Martin Perez-Santos

  8. Recent Patents in Cancer by Latin American Countries

    Article • Recent Patents on Anti-Cancer Drug Discovery, January 2017, Bentham Science Publishers

    PhD Martin Perez-Santos